Cargando…

Are Selective Beta-Adrenoceptor Blocking Drugs an Advantage?

Detalles Bibliográficos
Autor principal:	Kendall, M.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of Physicians of London 1981
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377628/ https://www.ncbi.nlm.nih.gov/pubmed/6109778

Ejemplares similares

Beta-Adrenoceptor Blocking Drugs and the Elderly
por: Wilkins, M. R., et al.
Publicado: (1984)

Uses of Beta-Adrenoceptor Blocking Drugs
por: Prichard, B. N. C., et al.
Publicado: (1976)

Slow Release Beta Adrenoceptor Blocking Drugs
por: Harron, D. W. G., et al.
Publicado: (1983)

Treatment of Hypertension with Beta-Adrenoceptor Blocking Drugs
por: Bai, Tony R., et al.
Publicado: (1982)

Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?
por: Bardou, Marc, et al.
Publicado: (2007)

Exploring the kinetic selectivity of drugs targeting the β(1)‐adrenoceptor
por: Sykes, David A., et al.
Publicado: (2022)

Roles of Beta2- and Beta3-Adrenoceptor Polymorphisms in Hypertension and Metabolic Syndrome
por: Masuo, Kazuko
Publicado: (2010)

Increased Beta2-Adrenoceptors in Doxorubicin-Induced Cardiomyopathy in Rat
por: Merlet, Nolwenn, et al.
Publicado: (2013)

Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology
por: Wenzel, Katrin, et al.
Publicado: (2018)

Beta-adrenoceptor regulates miRNA expression in rat heart
por: Hou, Yunlong, et al.
Publicado: (2012)

Celiprolol: A Unique Selective Adrenoceptor Modulator
por: Nawarskas, James J., et al.
Publicado: (2017)

α(2)-adrenoceptor-mediated inhibition in the central amygdala blocks fear-conditioning
por: Holmes, N. M., et al.
Publicado: (2017)

Beta3-Adrenoceptor Agonists: Possible Role in the Treatment of Overactive Bladder
por: Igawa, Yasuhiko, et al.
Publicado: (2010)

Beta(1)-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation
por: Nia, Amir M., et al.
Publicado: (2010)

Urinary beta 3-adrenoceptor as a diagnostic biomarker for overactive bladder in women
por: Liang, Ching-Chung, et al.
Publicado: (2023)

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells
por: Alaskar, Aljoharah, et al.
Publicado: (2022)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2022)

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2021)

Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist
por: Beeh, Kai M, et al.
Publicado: (2010)

Conformationally Selective RNA Aptamers Allosterically Modulate the β(2)-Adrenoceptor
por: Kahsai, Alem W., et al.
Publicado: (2016)

Total Beta-Adrenoceptor Knockout Slows Conduction and Reduces Inducible Arrhythmias in the Mouse Heart
por: Stöckigt, Florian, et al.
Publicado: (2012)

A Selective Pharmacophore Model for β(2)-Adrenoceptor Agonists
por: Xing, Rui-Juan, et al.
Publicado: (2009)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G.W., et al.
Publicado: (2022)

Metabolic Responses to Beta(2) Stimulants
por: Smith, S. Rolf, et al.
Publicado: (1984)

Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors
por: Meyer, Francisca, et al.
Publicado: (2014)

The Role of Adrenoceptors in the Retina
por: Ruan, Yue, et al.
Publicado: (2020)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2020)

The Clinical Pharmacology of Beta Adrenergic Blocking Drugs
por: McDevitt, D. G., et al.
Publicado: (1976)

To beta block or not to beta block; that is the question
por: Ince, Can
Publicado: (2015)

Novel selective β(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease
por: Baker, Jillian G., et al.
Publicado: (2017)

The Role of Adrenoceptors in Bronchial Asthma
por: Patel, K. R.
Publicado: (1979)

Relationships of Adrenoceptor Polymorphisms with Obesity
por: Masuo, Kazuko, et al.
Publicado: (2011)

Hydro-ethanolic Extract of Portulaca oleracea Affects Beta-adrenoceptors of Guinea Pig Tracheal Smooth Muscle
por: Boskabady, Mohammad Hossein, et al.
Publicado: (2016)

Nonselective beta-adrenoceptor blocker use and risk of Parkinson’s disease: from multiple real-world evidence
por: Feng, Zeying, et al.
Publicado: (2023)

Partial Mechanical Unloading of the Heart Disrupts L-Type Calcium Channel and Beta-Adrenoceptor Signaling Microdomains
por: Wright, Peter T., et al.
Publicado: (2018)

Spotting fruit versus picking fruit as the selective advantage of human colour vision
por: Bompas, Aline, et al.
Publicado: (2013)

A Full Pharmacological Analysis of the Three Turkey β-Adrenoceptors and Comparison with the Human β-Adrenoceptors
por: Baker, Jillian G.
Publicado: (2010)

β(1) Adrenoceptor antagonistic effects of the supposedly selective β(2) adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts
por: Pecha, Simon, et al.
Publicado: (2015)

Adrenal adrenoceptors in heart failure
por: de Lucia, Claudio, et al.
Publicado: (2014)

PENG block: Advantages of out-of-plane approach
por: Lopez-Lopez, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibmem6hs7030n0ht92pn54pkg3